Table 1.
Comparison of demographics and operative characteristics between patients who were continent at 1 month following a RARP and the remaining cohort
| Total (n = 327) | Continent at 1 month (n = 144) | Incontinent at 1 month (n = 183) | p value | |
|---|---|---|---|---|
| Age, median (IQR) | 60 (55–65) | 59 (54–63) | 62 (57–66) | 0.001 |
| ≤55 | 88 | 50 (57%) | 38 (43%) | 0.002 |
| 56–65 | 166 | 70 (42%) | 96 (58%) | |
| ≥66 | 73 | 24 (33%) | 49 (67%) | |
| BMI, median (IQR) | 27 (25–30) | 27 (24–29) | 27 (25–30) | 0.118 |
| Preoperative PSA, median (IQR) | 5.3 (4.2–7.4) | 5.0 (4.1–7.1) | 5.6 (4.2–7.6) | 0.164 |
| Prostate weight, median (IQR) | 45 (37–57) | 44 (36–54) | 47 (38–60) | 0.055 |
| Preoperative IPSS | 0.025 | |||
| Mild (0–7) | 198 | 99 (50%) | 99 (50%) | |
| Moderate (8–19) | 108 | 37 (34%) | 71 (66%) | |
| Severe (20–35) | 21 | 8 (38%) | 13 (62%) | |
| Preoperative SHIM | 0.107 | |||
| No ED (22–25) | 162 | 80 (49%) | 82 (51%) | |
| Mild (17–21) | 82 | 32 (34%) | 50 (61%) | |
| Mild to moderate (12–16) | 36 | 18 (50%) | 18 (50%) | |
| Moderate (8–11) | 10 | 2 (20%) | 8 (80%) | |
| Severe (1–7) | 37 | 12 (32%) | 25 (68%) | |
| Nerve-sparing | 0.089 | |||
| None | 74 | 28 (38%) | 46 (62%) | |
| Unilateral | 52 | 18 (35%) | 34 (65%) | |
| Bilateral | 201 | 98 (49%) | 103 (51%) | |
| pStage | 0.632 | |||
| T2 | 236 | 102 (43%) | 134 (57%) | |
| T3 | 91 | 42 (46%) | 49 (54%) |
RARP: robot-assisted radical prostatectomy; IQR: interquartile range; IPSS: International prostate symptom score; PSA: prostate-specific antigen; SHIM: sexual health inventory for men; ED: erectile dysfunction.